INTRODUCTION: There is evidence that immunological factors may involved in pathogenetic mechanisms of amyotrophic lateral sclerosis (ALS). Few studies to date have explored the status of the systemic immune response in patients with ALS. PATIENTS AND METHODS: In order to examine whether systemic immune activation is observed in patients with ALS, we measured the number of T cell subsets by flow cytometry in 36 patients with ALS and 35 normal controls. RESULTS: CD8 cytotoxic T cells and natural killer (NK) T cells were significantly increased in our patients with ALS compared with the control group (P = 0.02 and P = 0.04, respectively). Treg cells were significantly reduced compared with normal controls (P = 0.01). Treg cells were also negatively correlated with progression of the disease (P = 0.017). CONCLUSIONS: Our results suggest a systemic immune activation in patients with ALS. The high production of CD8(+) T and NKT cells may suggest an immunological reaction to some unknown or undetected endogenous proteins or viruses. A probably dual (neurodestructive or neuroprotective) inflammatory function of Treg cells cannot be excluded.
INTRODUCTION: There is evidence that immunological factors may involved in pathogenetic mechanisms of amyotrophic lateral sclerosis (ALS). Few studies to date have explored the status of the systemic immune response in patients with ALS. PATIENTS AND METHODS: In order to examine whether systemic immune activation is observed in patients with ALS, we measured the number of T cell subsets by flow cytometry in 36 patients with ALS and 35 normal controls. RESULTS:CD8 cytotoxic T cells and natural killer (NK) T cells were significantly increased in our patients with ALS compared with the control group (P = 0.02 and P = 0.04, respectively). Treg cells were significantly reduced compared with normal controls (P = 0.01). Treg cells were also negatively correlated with progression of the disease (P = 0.017). CONCLUSIONS: Our results suggest a systemic immune activation in patients with ALS. The high production of CD8(+) T and NKT cells may suggest an immunological reaction to some unknown or undetected endogenous proteins or viruses. A probably dual (neurodestructive or neuroprotective) inflammatory function of Treg cells cannot be excluded.
Authors: Benjamin J Murdock; Tingting Zhou; Samy R Kashlan; Roderick J Little; Stephen A Goutman; Eva L Feldman Journal: JAMA Neurol Date: 2017-12-01 Impact factor: 18.302
Authors: Jenny S Henkel; David R Beers; Shixiang Wen; Andreana L Rivera; Karen M Toennis; Joan E Appel; Weihua Zhao; Dan H Moore; Suzanne Z Powell; Stanley H Appel Journal: EMBO Mol Med Date: 2012-11-09 Impact factor: 12.137
Authors: Jessica A Hutter Saunders; Katherine A Estes; Lisa M Kosloski; Heather E Allen; Kathryn M Dempsey; Diego R Torres-Russotto; Jane L Meza; Pamela M Santamaria; John M Bertoni; Daniel L Murman; Hesham H Ali; David G Standaert; R Lee Mosley; Howard E Gendelman Journal: J Neuroimmune Pharmacol Date: 2012-10-11 Impact factor: 4.147
Authors: Jared S Katzeff; Fiona Bright; Katherine Phan; Jillian J Kril; Lars M Ittner; Michael Kassiou; John R Hodges; Olivier Piguet; Matthew C Kiernan; Glenda M Halliday; Woojin Scott Kim Journal: Brain Date: 2022-06-03 Impact factor: 15.255
Authors: Mengli Wang; Zhen Liu; Juan Du; Yanchun Yuan; Bin Jiao; Xuewei Zhang; Xuan Hou; Lu Shen; Jifeng Guo; Hong Jiang; Kun Xia; Jianguang Tang; Ruxu Zhang; Beisha Tang; Junling Wang Journal: Front Neurol Date: 2021-06-24 Impact factor: 4.003